Low-dose-contrast Cardiac Computed Tomography

Completed

Conditions studied: Aortic Stenosis

In brief

Low-dose-contrast CCTA can effectively and safely assess the aortic valve apparatus, and effectively direct the trans-catheter heart valve (THV) size selection by providing accurate annulus sizing, and provide adequate pre-procedural risk-stratification guidance for TAVR/TAVI.

Key facts

Study ID

NCT02146768

Run by

Baylor Research Institute

People needed

142

Starts

2014-01-01

Last updated by the study team

2017-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• > 18 years of age (75 patients who received low-dose contrast matched by body mass index with 75 patients who received traditional dose contrast) seen at THHBP between January 1, 2011 and June 30, 2013

You may not qualify if…

• Patients with MDRD eGFR < 25 will be excluded

Where it is running

• Center for Advance Cardiac Care — Plano, Texas, United States
• The Heart Hospital Baylor Plano — Plano, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.